Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Surging Nephrology Disorders Fuel Adoption of Serological Transplant Diagnostics: Fact.MR

This image opens in the lightbox

News provided by

Fact.MR

24 Feb, 2021, 14:00 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, Feb. 24, 2021 /PRNewswire/ -- Award winning market research company Fact.MR has recently published a report on the global serological transplant diagnostics market. According to the study, the market is expected to receive significant impetus in 2021 as organ transplantation procedures acquire momentum after a brief lull experienced due to the COVID-19 pandemic. Long-term prospects appear modest, with Fact.MR projecting a CAGR of 2.5% through 2031.

Growth is majorly underpinned by increasing incidences of nephrology disorders. According to the Global Burden of Disease (GBD) study published in 2015, 1.2 million people succumbed to kidney failure, representing an increase of 32% since 2005. Furthermore, in 2010, approximately 2.3 to 7.1 million people died of end stage kidney disease, without access to chronic dialysis. In addition, kidney diseases compels high-income countries to allocate over 2-3% of annual healthcare budget for their treatment.

Attributed to the aforementioned statistics, prominent manufacturers are introducing a slew of innovative serological transplant diagnostics solutions. Bridge to Life, for instance, manufactures the Belzer UW Machine Perfusion Solution for in-vitro flushing and continuous hypothermic machine perfusion preservation of explanted kidneys. The solution consists of a potassium concentration equivalent to 25 mEq/L and sodium of 100 mEq/L. Similarly, Biolasol offers a solution comprising of dextran, anhydrous glucose and sodium citrate which supports the preservation of the functional integrity of kidneys, liver, pancreas and the heart.

"Prominent serological transplant diagnostics manufacturers and suppliers are foraying into emerging economies, particularly across the developing world, attributed to the increasing prevalence of nephrology and cardiac ailments, opening up significant revenue pools throughout the forecast period," says a Fact.MR analyst.  

For More Insights into the Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=5566 

Key Takeaways from Fact.MR's Serological Transplant Diagnostics Market Study

  • Spurt in serological transplant reagents & testing kits sales to bolster market growth
  • By application, kidney and liver transplant operations are expected to fuel future sales
  • Hospitals to remain primary serological transplant diagnostics point-of-contact
  • Increasing prevalence of cardiovascular ailments to augment serological transplant diagnostics uptake in the US
  • UK and Germany to receive tailwinds amid increasing number of kidney transplants to cure nephrology ailments
  • Rising prevalence of respiratory disorders facilitating lung transplants across China, uplifting growth prospects
  • India to emerge as a highly lucrative market, attributed to the prevalence of numerous chronic diseases

Competitive Landscape

Prominent serological transplant diagnostics providers profiled by Fact.MR include Becton Dickinson & Company, Thermo Fisher Scientific, Bio Rad Laboratories, Agena Bioscience Inc., Avioq Inc., Bag Health Care GmbH, Immucor Inc., Siemens Healthineers and Produkte GmbH among others.

Manufacturers concentrate on offer treatment specific diagnostic services. For example, Thermo Fisher Scientific Inc. released the LABScreen COVID Plus serological assay targeted towards transplant candidates and recipients for detecting presence of the novel coronavirus. The product represents a leading in-vitro diagnostic product.

Bio Rad Laboratories, a prominent clinical diagnostics solutions provider, offers the Open EIA Microplate Analysis System for serological transplants. These assays can be performed using manual, semi-automated or fully-automated instrument systems. The company also offers serology reagents for detecting the presence of Retrovirus HIV, Hepatitis A, B, C and D, specific IgM and IgG antibodies for determining infectious mononucleosis, pediatric diseases, prenatal and congenital diseases, STDs and febrile and tropical diseases among others.   

Get Customization on this Report for Specific Country

https://www.factmr.com/connectus/sample?flag=RC&rep_id=5566 

Market players are also leveraging collaborative agreements to increase their penetration into potential markets. For instance, in 2018, Agena Bioscience Inc. announced a strategic partnership with Simcere Diagnostics (Simceredx), a subsidiary of SIMCERE Pharmaceutical Group, for the purpose of developing and commercializing companion diagnostics across China. This partnership was conducted with a view to expand pharmacological testing and support diagnostics for drug delivery pipelines.

More Insights on the Serological Transplant Diagnostics Market

In its latest report, Fact.MR offers unbiased analysis of the global serological transplant diagnostics market, providing historical data for the period of 2016-2020 and forecast statistics for 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (reagents & accessories, and systems), application (kidney transplantation, liver transplantation, heart transplantation, lung transplantation, and others), and distribution channel (hospitals, blood banks & transplant centres, donor registries & research laboratories), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Key Questions Covered in the Report

  • Which prominent manufacturers and suppliers operate in the global serological transplant diagnostics market?
  • Which is the primary application area for serological transplant diagnostics?
  • How will the global serological transplant diagnostics market expand through 2021?
  • How lucrative is the opportunity in the North American market?
  • Why are prominent serological diagnostic equipment suppliers eyeing India as a potential investment destination?

Request More Information about Report Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=5566 

Explore Fact.MR's Coverage on the Healthcare Domain

Cervical Dysplasia Diagnostics Market: A recent study by Fact.MR on the cervical dysplasia diagnostics market offers a 10-year forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with cervical dysplasia diagnostics.

Diabetes Diagnostics Market: A recent study by Fact.MR on the diabetes diagnostics market offers a 10-year forecast. The study analyzes crucial trends that are currently determining the growth of the diabetes diagnostics market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders.

Medical Suction Devices Market: A detailed assessment of the medical suction devices value chain analysis, business execution, and supply chain analysis across regional markets has been covered in Fact.MR's extensive report. Projections for future growth have been elaborated upon, based on prominent potential across key geographies and major segments for the upcoming decade.

About Fact.MR

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

Contact:

Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Logo: https://mma.prnewswire.com/media/713666/FactMR_Logo.jpg

Modal title

Also from this source

Bisabolene Market is Forecasted to Reach US$ 4.6 Million by 2034, Expanding at a CAGR of 3.9% | Fact.MR Report

According to a new research report published by Fact.MR, the global Bisabolene Market was valued at US$ 3 million in 2023 and has been forecasted to...

Hyaluronic Acid Raw Material Market is projected to grow at a CAGR of 5.2%, Reaching a value of $11.7 billion by 2034 | Fact.MR Report

The global Hyaluronic Acid Raw Material Market has been valued at US$ 7.05 billion in 2024, as stated in the recently updated industry analysis by...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.